alexa Human papillomavirus and cervical cancer: burden of illness and basis for prevention.
Oncology

Oncology

Journal of Cancer Science & Therapy

Author(s): Trottier H, Franco EL

Abstract Share this page

Abstract Genital infection with human papillomaviruses (HPV) is one of the most common sexually transmitted conditions. The central causal role in cervical carcinogenesis of the so-called high oncogenic-risk (HR)-HPV genotypes, such as HPV-16, has been established as a likely but not sufficient cause of virtually all cases of cervical cancer worldwide. HR-HPV infection also causes a substantial proportion of other anogenital neoplasms and oral squamous cell carcinomas. Infection with low-oncogenic-risk HPV, such as HPV-6 and -11, causes a large proportion of low-grade squamous intraepithelial lesions of the cervix and benign lesions of the anogenital areas known as condylomata acuminata (genital warts). Subclinical and clinical HPV infections are responsible for high morbidity and impose a great burden on the healthcare system. Organized or opportunistic screening with Papanicolaou (Pap) cytology in high-income countries has substantially reduced cervical cancer morbidity and mortality during the last 50 years. However, Pap cytology screening has failed to reduce cervical cancer mortality in many middle-income countries, and most low-income countries cannot make the necessary public health investments to deploy organized screening. The availability of 2 prophylactic HPV vaccines represents the best hope for preventing most cases of cervical cancer and HPV-associated diseases.
This article was published in Am J Manag Care and referenced in Journal of Cancer Science & Therapy

Relevant Expert PPTs

Relevant Speaker PPTs

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords